PRESENTATIONNATION

PRESENTATIONNATION

Browse a growing database of presentations shared by companies worldwide.

Browse

Browse All
All Companies
Presentations
Infographics
Reports
Brochures

Company

Blog
About
Contact

Legal

Privacy Policy
Terms of Service

© 2026 Presentation Nation. All rights reserved.
Built in San Diego by Twenty6 Red, Inc.

2019.05_OMP%20Investor%20Presentation_vF2 - Oasis Midstream Partners | Presentation Nation

HomepageOasis Midstream Partners2019.05_OMP%20Investor%20Presentation_vF2

2019.05_OMP%20Investor%20Presentation_vF2

Oasis Midstream Partners

Browse presentations, reports, and documents from Oasis Midstream Partners.

Tags

2019

Filter options

All (12)●
presentation (12)○

Get the best presentations in your inbox

Join professionals who get a weekly curated collection of top business presentations, investor decks, and industry reports — free.

No spam. Unsubscribe anytime.

Loading viewer...

presentation

Format: PDF presentation

Share:

2019.05_OMP%20Investor%20Presentation_vF2 by Oasis Midstream Partners.

Browse all presentations →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Oasis Midstream Partners

2018.08_OMP%20Investor%20Presentation_v7

presentation

2018.11_OMP%20Investor%20Presentation_v10

presentation

Similar presentations from other companies

Introduction%20to%20Ascential%202022.pptx

presentation

Ascential

Apollo Commercial Real Estate Finance_October_2020_477_61477.PDF

presentation

Apollo Commercial Real Estate Finance

2019.01_OMP%20Investor%20Presentation_vFinal

presentation

2019.05_OMP%20Investor%20Presentation_vF5-10

presentation

2019.08_OMP%20Investor%20Presentation_v7

presentation

May%202018%20OMP%20Presentation

presentation

Altria Group_May_2018_23_28023

presentation

Altria Group

Neste Corporation__2023__923_92923

presentation

Neste

China+Online+Education+Group+Q2+2020+Earnings+Presentation

presentation

China Online Education Group

Aeglea BioTherapeutics_June_2019_164_43164

presentation

Aeglea BioTherapeutics